source
- ObesityWeek 2026 to showcase amylin pathway and emerging weight-loss mechanismsObesityWeek 2026 starts Saturday in Washington, DC, gathering weight-loss experts and biopharma companies with metabolic assets. The meeting will highlight the amylin pathway and other emerging me…
- FDA issues warning letters to three Chinese API makers over record refusals and quality oversight lapsesThe FDA sent warning letters to three active pharmaceutical ingredient manufacturers based in China. Two firms were cited for refusing the agency's requests for records, while the third was found…